These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6208705)

  • 21. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha 2-macroglobulin: an introduction.
    Harpel PC; Brower MS
    Ann N Y Acad Sci; 1983; 421():1-9. PubMed ID: 6202181
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic values of alpha2-macroglobulin, fibrinogen and albumin in regards to mortality and frailty in old rats.
    Mayot G; Vidal K; Martin JF; Breuillé D; Blum S; Obled C; Papet I
    Exp Gerontol; 2007 Jun; 42(6):498-505. PubMed ID: 17337146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the determination of trypsin and chymotrypsin inhibitor capacity in human serum].
    Freimuth U; Büchner M; Fordran J
    Z Med Labortech; 1968; 9(6):361-4. PubMed ID: 5730747
    [No Abstract]   [Full Text] [Related]  

  • 26. Levels of total alpha-macroglobulin and trypsin-like immunoreactivity are poor indicators of clinical severity in spontaneous canine acute pancreatitis.
    Ruaux CG; Atwell RB
    Res Vet Sci; 1999 Aug; 67(1):83-7. PubMed ID: 10425245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation.
    Sahni A; Baker CA; Sporn LA; Francis CW
    Thromb Haemost; 2000 May; 83(5):736-41. PubMed ID: 10823272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of soluble myelin basic protein to various conformational forms of alpha2-macroglobulin.
    Gunnarsson M; Jensen PE
    Arch Biochem Biophys; 1998 Nov; 359(2):192-8. PubMed ID: 9808760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The properties of rabbit alpha1-macroglobulin upon activation are distinct from those of rabbit and human alpha2-macroglobulins.
    Banbula A; Chang LS; Beyer WF; Bohra CL; Cianciolo GJ; Pizzo SV
    J Biochem; 2005 Nov; 138(5):527-37. PubMed ID: 16272565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
    Gerner C; Steinkellner W; Holzmann K; Gsur A; Grimm R; Ensinger C; Obrist P; Sauermann G
    Thromb Haemost; 2001 Mar; 85(3):494-501. PubMed ID: 11307821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein binding of pancreatic proteolytic enzymes.
    HAVERBACK BJ; DYCE B; BUNDY HF; WIRTSCHAFTER SK; EDMONDSON HA
    J Clin Invest; 1962 May; 41(5):972-80. PubMed ID: 13905481
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential binding properties of human pregnancy zone protein- and alpha2-macroglobulin-proteinase complexes to low-density lipoprotein receptor-related protein.
    Chiabrando GA; Vides MA; Sánchez MC
    Arch Biochem Biophys; 2002 Feb; 398(1):73-8. PubMed ID: 11811950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
    Ohlsson F; Balldin G; Lasson A
    Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
    [No Abstract]   [Full Text] [Related]  

  • 38. Force spectroscopy of the fibrin(ogen)-fibrinogen interaction.
    Chtcheglova LA; Haeberli A; Dietler G
    Biopolymers; 2008 Apr; 89(4):292-301. PubMed ID: 18098176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conformational state of human alpha 2-macroglobulin influences its dissociation into half-molecules by sodium thiocyanate.
    Shanbhag VP; Stigbrand T; Jensen PE
    Arch Biochem Biophys; 1996 Sep; 333(1):35-41. PubMed ID: 8806751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.